Category

Daily Briefs

Daily Brief Consumer: Kusuri no Aoki Holdings , Netflix Inc, Samson Holding, Com7 , Astra International, China Resources Beverage, Oriental Watch, Modine Manufacturing Co, BellRing Brands and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Kusuri No Aoki (3549) Big Buyback – Accretive, And May Involve Musical Shares
  • How Netflix is upending Hollywood
  • Samson (531 HK): 21 Oct Shareholder Vote
  • Samson Holding (531 HK): Scheme Vote on 21 October
  • SET50 Index Rebalance Preview: Four Changes as Adds Outperform Deletes
  • Astra International (ASII IJ) – Digging in Against the BEV Threat
  • CR Beverage IPO: The Investment Case
  • Oriental Watch 398 HK Earnings Preview H1 FY25: Resilient at 7.2x PE, 14% Yield, 52% Mkt Cap in Cash
  • Modine Manufacturing Company: Market-Driven Product Adjustments In Heating & Cooling & Diversification In Performance Technologies! – Major Drivers
  • Bellring Brands (BRBR) – Wednesday, Jul 3, 2024


Kusuri No Aoki (3549) Big Buyback – Accretive, And May Involve Musical Shares

By Travis Lundy

  • The drugstore space in Japan is super-interesting. The stories, the mergers, the activists. And of course, the defence against activists.
  • In Feb-2024, Aeon did a deal with an activist to cause a future deal between Tsuruha and Welcia. Aeon also owns a stake in Kusuri no Aoki Holdings (3549 JP)
  • The Aoki brothers (CEO and VP) exercised warrants in August and re-arranged their holdings. Now the family owns 34.7%. Today, after Q1 earnings, the company announced a 5+% buyback.

How Netflix is upending Hollywood

By Behind the Money

  • Netflix recently hit an all-time high on the stock market, capitalizing on the chaos in the entertainment industry
  • The company was initially seen as a renegade tech startup, leading the streaming market with its first mover advantage
  • After reporting a loss in subscribers, Netflix announced plans to launch an advertising-supported business to combat competition in the streaming wars.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Samson (531 HK): 21 Oct Shareholder Vote

By David Blennerhassett

  • Back on the 16th July, furniture trader Samson Holding (531 HK) announced an Offer, by way of a Scheme, from Shan Huei Kuo, Samson’s Chairman.
  • The Cancellation Price is $0.48/share (final), a 50% premium to last close; but more notable if going back a month. This looks done. However, Samson is an illiquid micro-cap.
  • The Scheme Doc is now out, with a Court Meeting to be held on the 21st October. Expected payment on the 14 November. The IFA says fair & reasonable.

Samson Holding (531 HK): Scheme Vote on 21 October

By Arun George

  • Samson Holding (531 HK)’s IFA opines that Mr Samuel Kuo (Chairman)’s HK$0.48 privatisation offer to be fair and reasonable. The vote is on 21 October. 
  • Key conditions include approval by at least 75% of independent shareholders (<10% of independent shareholders rejection). Despite the market rally, most peers’ shares have declined since the offer announcement. 
  • The attractive premium, lack of shareholders holding a blocking stake, and low AGM minority participation rate point to a done deal. At the last close, the gross/annualised spread is 3.2%/29.8%.

SET50 Index Rebalance Preview: Four Changes as Adds Outperform Deletes

By Brian Freitas


Astra International (ASII IJ) – Digging in Against the BEV Threat

By Angus Mackintosh

  • Astra International is well-positioned to fend off the challenge of incoming EV players to Indonesia, a country far more suited to Hybrid EVs, with little charging infrastructure.
  • Despite new entrants, the company has maintained its market share at 57% YTD, with Chinese EV makers fighting amongst themselves and other Japanese ICE brands losing some share. 
  • Astra continues to develop new HEV products, with a line up of 10 BEVs due by 2028 from Toyota but investments in the ecosystem are already underway. Valuations remain attractive.

CR Beverage IPO: The Investment Case

By Arun George


Oriental Watch 398 HK Earnings Preview H1 FY25: Resilient at 7.2x PE, 14% Yield, 52% Mkt Cap in Cash

By Sameer Taneja

  • Oriental Watch (398 HK) will report its H1 FY25 result in mid-November. We expect earnings to be down 5-10% YoY, as SSSG would be flattish for the period.
  • We expect a 25-26 cent dividend ( ~14% yield annualized). With the stimulus measures in place, we expect China’s mood to be slightly more upbeat.
  • Oriental Watch (398 HK) goes ex-dividend today (23.5 cent/share dividend). As we enter trading today, it may be available at a higher yield. 

Modine Manufacturing Company: Market-Driven Product Adjustments In Heating & Cooling & Diversification In Performance Technologies! – Major Drivers

By Baptista Research

  • Modine Manufacturing Company reported a strong start to Fiscal 2025, showcasing significant growth and operational successes across its segments.
  • The company’s proactive strategic initiatives, including acquisitions and the implementation of a transformative 80/20 business strategy, have evidently positioned it well for sustainable growth.
  • However, adjustments in performance expectations in specific segments highlight the ongoing adaptation to market conditions.

Bellring Brands (BRBR) – Wednesday, Jul 3, 2024

By Value Investors Club

  • BellRing Brands, created through acquisitions by Post Holdings, has experienced substantial growth, with its stock price increasing from $20 to $59 since its last write-up on VIC over four years ago.
  • While some brands like Powerbar and Dymatize have underperformed, Premier Protein has been a standout success for BellRing Brands.
  • With anticipated sales of $2 billion and EBITDA of $410 million for fiscal year 2024, BellRing Brands is viewed as a compelling investment opportunity with a promising future and reasonable valuation.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Rigaku Holdings, Shenzhen Mindray Bio-Medical Electronics, Sichuan Biokin Pharmaceutical Co Ltd, Perrigo, Soligenix , Evaxion Biotech A/S, Nurexone Biologic, BrainStorm Cell Therapeutics I and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Rigaku Holdings (268A JP) IPO: The Bear Case
  • Rigaku IPO – Peer Comparison – Compensating for Smaller Scale with Better Growth and Margins
  • Shenzhen Mindray (300760 CH): Sustained Growth Momentum; China Recovery To Provide Further Filip
  • Pre-IPO Sichuan Biokin Pharmaceutical – Would Investors Be Willing to Take a Gamble?
  • Perrigo Co Plc (PRGO) – Thursday, Jul 4, 2024
  • SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development
  • EVAX: Trial Suggests AI Improves Performance
  • Nurexone Biolgc : Initiating Coverage: Potential Breakthrough Treatment for Spinal Injuries
  • BrainStorm Cell Therapeutics (BCLI) Update Note 03102024


Rigaku Holdings (268A JP) IPO: The Bear Case

By Arun George

  • Rigaku Holdings (268A JP) is Japan’s leading manufacturer of X-ray analysis, measurement and testing instruments. It is seeking to raise up to US$760 million.
  • In Rigaku Holdings (268A JP) IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on weakening forward growth indicators, China revenue risk, rising cash conversion cycles, mid-tier FCF margin and large post-IPO share overhang. 

Rigaku IPO – Peer Comparison – Compensating for Smaller Scale with Better Growth and Margins

By Clarence Chu

  • Rigaku Holdings (268A JP) is looking to raise US$762m in its Japan IPO.
  • Rigaku engages in developing, manufacturing, sales and servicing scientific instruments specializing in X-ray technologies.
  • In our earlier notes, we looked at the firm’s past performance. In this note, we undertake a peer comparison.

Shenzhen Mindray (300760 CH): Sustained Growth Momentum; China Recovery To Provide Further Filip

By Tina Banerjee

  • Shenzhen Mindray Bio-Medical Electronics (300760 CH) reported double-digit growth in revenue and net profit in 1H24.
  • In-Vitro diagnostics and medical imaging systems segments drive performance, while patient monitoring and life support lagged.
  • International market continues to show strength, while China lingers for now.

Pre-IPO Sichuan Biokin Pharmaceutical – Would Investors Be Willing to Take a Gamble?

By Xinyao (Criss) Wang

  • Biokin’s traditional chemical drug and TCM businesses would continue to shrink and their valuation contribution can be negligible. The collaboration agreement for BL-B01D1 with BMS changes the outlook of Biokin.
  • The clinical data of BL-B01D1 look good so far, but the R&D failure risk of BL-B01D1 is not low. It is uncertain if BL-B01D1 would finally be druggable.
  • Biokin is overvalued and there is big bubble in valuation. If BL-B01D1 fails in R&D or its clinical data fail to meet high expectation, Biokin’s market value will plummet.

Perrigo Co Plc (PRGO) – Thursday, Jul 4, 2024

By Value Investors Club

  • PRGO has resolved 90% of its challenges and is on track to address the remaining issues soon
  • Predicted rise in earning power by 2025 could boost estimates and valuation, with potential for $3.5 EPS and $45 price target
  • New CEO has shown progress in addressing issues, setting new expectations, and implementing cost-cutting measures, making PRGO an attractive investment opportunity with limited downside risk

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development

By Zacks Small Cap Research

  • On October 2, 2024, two travelers in Hamburg, Germany were hospitalized due to displaying symptoms consistent with Marburg virus.
  • The two travelers had recently arrived from Rwanda, a country that is currently experiencing an outbreak of the disease, and one of them had reportedly come into contact with someone later confirmed to be infected with Marburg virus.
  • Rwanda has had a total of 26 confirmed cases of Marburg virus, with eight deaths.

EVAX: Trial Suggests AI Improves Performance

By Zacks Small Cap Research

  • EVAX is a clinical stage company that has proprietary AI models designed to more efficiently and more accurately target much-needed treatments.
  • The company has two streams of possible revenue: from the treatments themselves and from the licensing of the AI technology.
  • The company announced that its Phase 2 trial of its personalized cancer vaccine improved its response rate significantly from Phase I-both improving the chances for FDA approval and validating the AI approach to medicine.

Nurexone Biolgc : Initiating Coverage: Potential Breakthrough Treatment for Spinal Injuries

By Zacks Small Cap Research

  • NurExone (OTC-NRXBF) is a clinical stage biotech company that is developing a breakthrough treatment for spinal cord injuries that has the potential to dramatically improve lives.
  • The technology involved also has the potential to more efficiently get other treatments to the needed area.
  • The company has conducted preclinical testing that has shown dramatic results and has been awarded an important FDA designation.

BrainStorm Cell Therapeutics (BCLI) Update Note 03102024

By ACF Equity Research

  • BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou Gehrig’s).
  • We have stress tested our valuation vs. current global and market events as well as and BCLI’s reverse stock split (R/S) 30 Sept 2024 (to maintain Nasdaq listing).
  • Whilst there are pros and cons – our risk adjusted WACC has increased and NPV reduced, our conservative base case expected dilution assumptions have improved with R/S and Nasdaq compliance and our base case return has risen to 8.5x, up 0.5x.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: Hong Kong Connect Flows (Sep): Weak Inflows Ex-Alibaba and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • Hong Kong Connect Flows (Sep): Weak Inflows Ex-Alibaba
  • KRX Short Interest Weekly (Sep 27th): Hmm, Samsung Electronics
  • Global Emerging Markets: Reporting Season Summary, 3Q2024


Hong Kong Connect Flows (Sep): Weak Inflows Ex-Alibaba

By Ke Yan, CFA, FRM

  • We analyze the monthly Hong Kong Connect flows with our data engine.
  • We tabulate the top stocks by inflows, outflows, and holding by mainland investors.
  • We highlight inflows into Alibaba, Kuaishou, Anta, HKEx, China Resource Land, China Telecom, and outflows from Meituan, Tencent, CNOOC, Xiaomi, China Mobile. 

KRX Short Interest Weekly (Sep 27th): Hmm, Samsung Electronics

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of KRX stocks as of Sep 27th which has an aggregated short interest worth USD5.3bn.
  • We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Hmm (011200 KS), Samsung Electronics (005930 KS).

Global Emerging Markets: Reporting Season Summary, 3Q2024

By Wium Malan, CFA

  • During 3Q2024, the 200 largest weighted companies in the GEM index reported average EPS growth of +14.3%y/y, accelerating from the +7.1% reported during 2Q2024.
  • Overall, 59% of companies delivered positive EPS surprises, and 63% delivered positive Sales surprises, a continuation of the positive trend witnessed in the previous quarter.
  • Historically, there has been a significant difference in relative share price performance between the largest positive versus negative surprise generators, for 3 months after the reporting date.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Slightly More than the Annual IPOs and more

By | Daily Briefs, ESG

In today’s briefing:

  • Slightly More than the Annual IPOs, 119 Companies Newly Applied for Transitional Measures This Year


Slightly More than the Annual IPOs, 119 Companies Newly Applied for Transitional Measures This Year

By Aki Matsumoto

  • Of the companies that have been removed from the list of companies subject to transitional measures, only about half have been able to meet the criteria for maintaining their listing.
  • It’s not easy for companies applying transitional measures to comply with the criteria for maintaining listing, so it’s realistic to move to a market with looser criteria for maintaining listing.
  • Besides problems with listing screening process, many managers consider IPO to be the goal and have little will to grow the company after listing, leading to slump in corporate value.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | Stocks Barely Budge and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | Stocks Barely Budge
  • Japan Morning Connection: Exporters to Jump on the Weak Yen
  • Mat-Chem Notes – Hurricanes, Port Strikes, Geopolitics, and Crosscurrents in EVs


Ohayo Japan | Stocks Barely Budge

By Mark Chadwick

  • U.S. stocks edged slightly higher Wednesday despite escalating Middle East tensions between Israel and Iran
  • UNIQLO reported a 22.1% increase in domestic same-store sales for September, marking six months of consecutive growth
  • Toyota Motor is delaying its electric vehicle production in North America from 2025 to early 2026, citing design adjustments and slowing EV sales in the U.S. market

Japan Morning Connection: Exporters to Jump on the Weak Yen

By Andrew Jackson

  • Further PM Ishiba flip-flopping on his previously hawkish rates policy, set to catch markets wrong footed today.
  • Homebuilders may face a bigger fallout than expected from hurricane Helene given the potential to squeeze margins as materials and workers are prioritized for emergency efforts.
  • Exporters including autos, R/E and tourism related names should see renewed interest on the weak yen.

Mat-Chem Notes – Hurricanes, Port Strikes, Geopolitics, and Crosscurrents in EVs

By Water Tower Research

  • WTR-CMI last week. Driven by the recovery in lithium stocks, our WTR-CMI index of 30 specialty chemicals and materials technology stocks rose 1.7% for the week, handily outperforming mostly flattish performance of large cap tech-heavy S&P 500 as well as the broader Russell 2000 indices.
  • YTD the WTR-CMI continues to outperform the Russell 2000 (13.6% vs. 9.8%) and on YoY basis our index nearly kept up with S&P 500’s strong 33.8% rise by appreciating 31.1% compared to Russell 2000’s 24.6% improvement.
  • Hurricane season kicks into high gear. While the impact of hurricane Helena are still being assessed, Francine’s impact on oil and gas production and barge traffic are already being felt in the markets, with gulf coast oil production down nearly 40% and natural gas production down nearly 50%, with barge fleets staying away from the region until weather settles, which now looks to be delayed due to Helena’s destructive path.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: China Resources Beverage Pre-IPO – PHIP Updates – Revenue Slowing and more

By | Daily Briefs, ECM

In today’s briefing:

  • China Resources Beverage Pre-IPO – PHIP Updates – Revenue Slowing, Margins Growing
  • Intermestic IPO: Forecasts and Valuation
  • The Cerebras IPO Stucture Sucks
  • China Resources Beverage Pre-IPO – Updated Thoughts on Valuation
  • Pre-IPO China Resources Beverage (PHIP Updates) – Some Points Worth the Attention


China Resources Beverage Pre-IPO – PHIP Updates – Revenue Slowing, Margins Growing

By Sumeet Singh

  • China Resources Beverage (CRB HK) is looking to raise up to US$1bn in its upcoming Hong Kong IPO. 
  • China Resources Beverage manufactures and sells packaged drinking water and RTD soft beverages in China.
  • In our earlier notes, we talked about the company’s past performance and provided our thoughts on valuations. In this note, we will look at updates from its most recent filings.

Intermestic IPO: Forecasts and Valuation

By Shifara Samsudeen, ACMA, CGMA

  • The Japanese eyewear company Intermestic (262A JP) has set the terms for its Tokyo IPO and plans to raise US$121m through the IPO.
  • Our analysis shows that the company’s IPO is valued attractively compared to JINS Inc (3046 JP) , who offers eyewear at a similar price range to Intermestic.
  • Japanese eyewear makers who have aggressively expanded into overseas markets seems to be suffering from falling sales and margins, particularly in China due to economic slowdown.

The Cerebras IPO Stucture Sucks

By Douglas O’Laughlin

  • I’m not going to write about the technical side at all, as I expect Dylan Patel’s team at SemiAnalysis to do a much better job than I can do alone.
  • However, I want to note some of the funniest aspects because landmines are everywhere for this IPO. Of course, it’s driven by G42, but it’s much worse than you think. Here’s the prelim S-1.
  • G42 is pretty much the only customer.

China Resources Beverage Pre-IPO – Updated Thoughts on Valuation

By Sumeet Singh

  • China Resources Beverage (CRB HK) is looking to raise up to US$1bn in its upcoming Hong Kong IPO.
  • China Resources Beverage manufactures and sells packaged drinking water and RTD soft beverages in China.
  • In our earlier notes, we talked about the company’s past performance and provided our initial thoughts on valuations. In this note, we will relook at valuations post its PHIP updates.

Pre-IPO China Resources Beverage (PHIP Updates) – Some Points Worth the Attention

By Xinyao (Criss) Wang

  • Nongfu Spring is able to take a price war to grab market share,but the strategy of CR Beverage forced to cut prices may not work,making its profit margin further decline.
  • CR Beverage’s business model is “single business + scale expansion”, worse than “multi-category structure + new product incubation”.Future performance growth may inevitably slow down if without the second growth curve.
  • Whether in terms of product/revenue structure, profitability, or sustainability of growth momentum, CR Beverage isn’t as good as Nongfu Spring. Valuation of CR Beverage should be lower than Nongfu Spring.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Morning Views Asia: Nickel Industries and more

By | Credit, Daily Briefs

In today’s briefing:

  • Morning Views Asia: Nickel Industries , Tata Motors ADR


Morning Views Asia: Nickel Industries , Tata Motors ADR

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Korea Zinc’s Buyback Tender Offer at ₩830 and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Korea Zinc’s Buyback Tender Offer at ₩830,000: Market Vibe Still Leans Towards MBK
  • Court Dismisses Injunction; Korea Zinc to Announce Buyback Tender Offer Soon
  • ASMPT (522 HK): Don’t Bet on a KKR Privatisation
  • GA Pack (468 HK): Crunch Time
  • Korea Zinc: Plans to Buy Back and Cancel Shares Worth 2.7 Trillion Won + Team Up with Bain Capital
  • ASMPT (ASM Pacific). 522 HK. M&A. Takeover Target Talk. Déjà Vu ?
  • CMCDI (133 HK)’s Proposals Light On Detail
  • ASMPT (522 HK): KKR’s Proposal Is A Non-Starter
  • KOSPI200 Index Rebalance Preview: 4 Adds, 5 Deletes Likely in December
  • Quiddity Leaderboard HSTECH Dec 24: Midea Group Question Mark and Final Rankings for Exp ADDs/DELs


Korea Zinc’s Buyback Tender Offer at ₩830,000: Market Vibe Still Leans Towards MBK

By Sanghyun Park

  • Korea Zinc is launching a 3.21M share buyback (15.5% of total shares) via a KRW 2.66T tender offer at ₩830,000 per share, with Bain Capital involved.
  • If tendered shares fall short, Korea Zinc and Bain Capital will buy all. If over the target, they’ll buy pro rata. Below 1,215,283 shares, they will opt out.
  • Should we dive into Korea Zinc’s risky buyback or choose safer, lower-priced MBK? The market vibe favors MBK, reflected in Korea Zinc’s closing price today.

Court Dismisses Injunction; Korea Zinc to Announce Buyback Tender Offer Soon

By Sanghyun Park

  • The court rejected MBK and Young Poong’s injunction to block Korea Zinc’s buyback, allowing Choi’s side to continue using buybacks to defend control.
  • Korea Zinc plans an emergency board meeting to launch a tender offer, using internal funds, to buy back shares at 800K-850K KRW starting around October 7.
  • If Choi converts discretionary reserves into distributable profits, Korea Zinc could unlock 2-3 trillion KRW for the buyback, but uncertainty keeps the stock around 700K KRW.

ASMPT (522 HK): Don’t Bet on a KKR Privatisation

By Arun George

  • Bloomberg reported that KKR has made a non-binding, preliminary approach to taking ASM Pacific Technology (522 HK) private. ASMPT has been the subject of takeover rumours in the past.
  • The trading patterns of the substantial shareholders suggest a willingness to exit. However, past privatisation rumours suggest issues with the offeror matching key shareholders’ price expectations. 
  • A binding proposal is unlikely as the timing would be viewed as opportunistic, with the recent market rally eroding a potential takeover premium and ASMPT’s premium multiple compared to peers.

GA Pack (468 HK): Crunch Time

By Arun George

  • Unsurprisingly, the Greatview Aseptic Packaging (468 HK) Board has recommended shareholders vote against the appointment of Shandong Xinjufeng Technology Packaging (301296 CH)’s two director nominees.
  • The EGM vote on 18 October is too close to call and depends on Shandong Xinjufeng and management’s ability to rally disengaged minorities to their respective causes.   
  • Irrespective of the EGM vote results, Shandong Xinjufeng will be keen to launch its offer to ward off the threat of a possible competing offer from management. 

Korea Zinc: Plans to Buy Back and Cancel Shares Worth 2.7 Trillion Won + Team Up with Bain Capital

By Douglas Kim

  • Korea Zinc plans to repurchase and cancel shares worth 2.663 trillion won. Korea Zinc’s partner Bain Capital also plans to purchase around 430 billion won for a 2.5% stake. 
  • Korea Zinc plans to buy back shares at 830,000 won per share, which is 11% higher than MBK’s revised up tender offer price of 750,000 won.
  • Choi family/Bain Capital’s efforts to conduct a massive share buyback and cancellation at higher prices than the market price goes against the globally accepted market practices.

ASMPT (ASM Pacific). 522 HK. M&A. Takeover Target Talk. Déjà Vu ?

By Neil Campling

  • The second PE rumoured interest in ASMPT in 18 months, with KKR circling.
  • Semiconductor M&A has surged in 2024 YTD with a 33% increase in deal activity compared to 2023.
  • ASM’s leadership in TCB, potential growth within HBM, expansion at TSM and enabling the Nvidia Blackwell platform are all reasons for M&A interest.

CMCDI (133 HK)’s Proposals Light On Detail

By David Blennerhassett

  • Argyle Street Management (ASM), a 9.01% shareholder in China Merchants China Direct Investments (133 HK), has been (very) publicly angling for change in this closed-end fund. Here is their website.
  • The core issue is CMCDI’s P/NAV ratio of 0.41x compared to closed-end fund peers of 0.8x-0.9x. 
  • CMCDI has finally responded to ASM’s overtures with the prospect of a share buyback and a special dividend. But details are thin on the ground. 

ASMPT (522 HK): KKR’s Proposal Is A Non-Starter

By David Blennerhassett

  • Reportedly – Bloomberg – KKR has made a non-binding proposal for ASM Pacific Technology (522 HK), the world’s leading back-end semiconductor production equipment supplier. 
  • ASMPT’s largest shareholder, ASM International Nv (ASM NA), with 25%, has been the focus of activists for some time to sell its stake. 
  • This bid has all the hallmarks of the approach (also cited by Bloomberg) by PAG last year. Which came to nought. From a regulatory standpoint, I can’t see this happening.

KOSPI200 Index Rebalance Preview: 4 Adds, 5 Deletes Likely in December

By Brian Freitas

  • 85% of the way through the review period, there could be 4 adds and 5 deletes for the Korea Stock Exchange KOSPI 200 (KOSPI2 INDEX) in December.
  • The impact on the potential inclusions ranges from 1.4-17 days of ADV while the impact on the potential deletions varies from 4-8 days of ADV.
  • The potential adds outperformed the potential deletes early in the review period before giving up all the gains over the following months.

Quiddity Leaderboard HSTECH Dec 24: Midea Group Question Mark and Final Rankings for Exp ADDs/DELs

By Janaghan Jeyakumar, CFA

  • The HSTECH Index tracks the performance of the top 30 technology companies listed in Hong Kong that have high business exposure to certain technology themes.
  • In this insight, we take a look at the final rankings of potential ADDs and potential DELs for the December 2024 index rebal event.
  • We do not expect any changes for the HSTECH index in December 2024. However, we expect there to be capping flows of US$1,079mn one-way.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Crypto: Market Musings – Reawakening The Animal Spirits and more

By | Crypto, Daily Briefs

In today’s briefing:

  • Market Musings – Reawakening The Animal Spirits


Market Musings – Reawakening The Animal Spirits

By Delphi Digital

  • The report from Delphi Digital discusses significant macroeconomic changes, including the Federal Reserve’s move to lower interest rates and China’s liquidity injections, creating a positive environment for risk assets such as cryptocurrencies.
  • In the crypto markets, there is growing optimism as BTC shows signs of a trend reversal and altcoins stage rallies.
  • ETF inflows, particularly in BTC, are increasing after a slow summer.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Dr Lal PathLabs Ltd (DLPL IN): Poised for Next Level of Growth Amid Easing Price Competition and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Dr Lal PathLabs Ltd (DLPL IN): Poised for Next Level of Growth Amid Easing Price Competition
  • Fast Retailing(9983) | Weaving a Global Empire; FY8/25 Outlook
  • Taiwan Tech Weekly: Apple Shifting AR Strategy After Meta Orion Showcase; Apple Supply Chain Monitor
  • Arena Bilgisayar (ARENA TI) – Tuesday, Jul 2, 2024
  • Wise Plc (WPLCF) – Tuesday, Jul 2, 2024
  • Shortlist of High Conviction Philippines Equity Ideas – October 2024
  • Mongolia Mining 975 HK: Redemption of Perpetual Securities Complete, Dividend Catalyst In-Play
  • Tech Supply Chain Tracker (03-Oct-2024): Taiwan’s carbon fee faces challenges from local, EU regs.
  • Pvh Corp – VNCE: European Tour: Creating Key Growth Vehicle; Reiterating Buy Rating, $3 PT
  • Sustainable Investing Surveyor – Atlas Lithium Corporation (ATLX)


Dr Lal PathLabs Ltd (DLPL IN): Poised for Next Level of Growth Amid Easing Price Competition

By Tina Banerjee

  • Dr Lal PathLabs Ltd (DLPL IN) has maintained its 10% revenue growth target for the current financial year, mainly driven by 6–7% growth in patient volume.
  • The operating environment is becoming conducive. Competitive intensity in terms of predatory pricing, promotional offer, and cash burning to acquire customers, have come to an end.
  • As of Q1FY25, DLPL has net cash position of INR10B. The company is looking for small or mid-sized acquisitions in South and West India and expanding in small towns.

Fast Retailing(9983) | Weaving a Global Empire; FY8/25 Outlook

By Mark Chadwick

  • Fast Retailing, through its flagship Uniqlo, is redefining retail by focusing on high-quality, functional apparel, surpassing global peers in operating profit margins.
  • The company’s “scrap & build” strategy revitalizes underperforming stores in China, while expanding internationally, with a strong growth trajectory across North America and Europe.
  • With a revised fair value of 52,500 yen, we forecast significant sales growth, driven by favorable seasonal trends, global expansion and recovering consumer sentiment in China.

Taiwan Tech Weekly: Apple Shifting AR Strategy After Meta Orion Showcase; Apple Supply Chain Monitor

By Vincent Fernando, CFA

  • Apple Set to Launch iPhone SE 4 and Updated iPad Air in Early 2025: Key Developments to Watch
  • META’s Orion AR Glasses: Next Major Computing Platform After the Smartphone?
  • Apple Supply Chain Monitor: Key IPhone Suppliers Didn’t Rally With Apple; Opportunity for Rebound?

Arena Bilgisayar (ARENA TI) – Tuesday, Jul 2, 2024

By Value Investors Club

  • Arena Bilgisayar is Turkey’s second-largest IT distributor led by CEO Serkan Celik, who has successfully turned around the core distribution business and created value from non-core ventures
  • Despite appearing undifferentiated, levered, and expensive on the surface, the company’s valuation is attractive at 1x tangible book value and 5-7x P/E ratio
  • With double-digit annual growth, pre-tax returns on capital exceeding 35%, and Turkey’s return to orthodox monetary policy, an investment in Arena could potentially return between 3-5x over the next 5 years, founded in 1991 by former Karma International employees, Arena has a strong history and promising future.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Wise Plc (WPLCF) – Tuesday, Jul 2, 2024

By Value Investors Club

  • Wise operates centers in different countries for faster and cost-effective cross-border transactions
  • Strong track record of organic growth in a growing market with high Total Addressable Market
  • Recent stock declines attributed to cyclical factors, but investors optimistic about Wise’s expanding product offerings and core FX payments supporting revenue growth

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Shortlist of High Conviction Philippines Equity Ideas – October 2024

By Sameer Taneja


Mongolia Mining 975 HK: Redemption of Perpetual Securities Complete, Dividend Catalyst In-Play

By Sameer Taneja

  • In a filing released last evening after the market, Mongolian Mining (975 HK) announced it had redeemed the entire outstanding principal amount of the perpetual securities and their distribution.
  • The announcement is significant as it prepares the company to distribute dividends for FY24 in the March results. 
  • The stock trades at 5.2x FY24 PE and 2.5x EV-EBITDA, and we expect the company to have massive net cash by the end of the year.

Tech Supply Chain Tracker (03-Oct-2024): Taiwan’s carbon fee faces challenges from local, EU regs.

By Tech Supply Chain Tracker

  • Taiwan’s carbon fee policy is being challenged by local and EU regulations, impacting their offshore wind goals.
  • Europe’s data center capacity shortage for the AI race is causing concerns in the region.
  • Samsung’s Galaxy Tab S10 series now includes MediaTek chips, bringing new capabilities to the familiar design.

Pvh Corp – VNCE: European Tour: Creating Key Growth Vehicle; Reiterating Buy Rating, $3 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, projections and $3 price target for Vince after meeting with management in their European headquarters and touring the Galeries Lafayette shop in shop in Paris.
  • We believe, with the company now well capitalized and acting in a materially more strategic fashion, the European opportunities, from owned stores to additional wholesale to category expansion, position Vince to drive material international growth going froward.
  • When coupled with strong product offerings and what we believe are material opportunities in the domestic market, we believe Vince is ideally positioned to register material top and bottom line growth, and we reiterate our Buy rating and $3 price target for VNCE.

Sustainable Investing Surveyor – Atlas Lithium Corporation (ATLX)

By Water Tower Research

  • The WTR Sustainable Index was up 3.5% W/W versus the S&P 500 Index (up 0.6%), the Russell 2000 Index (down 0.1%) and the Nasdaq Index (up 1.1%).
  • Energy Technology (13.5% of the index) was up 3.3%, while Industrial Climate and Ag Technology (46.3% of the index) was up 1.1%, ClimateTech Mining was up 4.2%, and Advanced Transportation Solutions (21.0% of index) was up 8.4%.
  • Top 10 Performers: VIHD, NNOMF, WAVE, EGT, NVVE, CPWHF, VLI, XPEV, MP, DNMR

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars